156 related articles for article (PubMed ID: 36180402)
1. Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials.
Lin Q; Xue Y; Zou H; Ruan Z; Ung COL; Hu H
Expert Rev Clin Pharmacol; 2022 Dec; 15(12):1461-1469. PubMed ID: 36180402
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Liraglutide 3.0 mg in Patients with Overweight and Obese with or without Diabetes: A Systematic Review and Meta-Analysis.
Konwar M; Bose D; Jaiswal SK; Maurya MK; Ravi R
Int J Clin Pract; 2022; 2022():1201977. PubMed ID: 35936066
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.
Khera R; Murad MH; Chandar AK; Dulai PS; Wang Z; Prokop LJ; Loomba R; Camilleri M; Singh S
JAMA; 2016 Jun; 315(22):2424-34. PubMed ID: 27299618
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy weight-loss interventions to prevent type 2 diabetes in overweight or obese adults and older adults: A protocol for systematic review and network meta-analysis.
Yang W; Wen J; Wu F; Zeng H; Guo B; Ge L
Medicine (Baltimore); 2021 Mar; 100(11):e24812. PubMed ID: 33725948
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial.
Garvey WT; Birkenfeld AL; Dicker D; Mingrone G; Pedersen SD; Satylganova A; Skovgaard D; Sugimoto D; Jensen C; Mosenzon O
Diabetes Care; 2020 May; 43(5):1085-1093. PubMed ID: 32139381
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of liraglutide 3.0 mg for weight management are similar across races: subgroup analysis across the SCALE and phase II randomized trials.
Ard J; Cannon A; Lewis CE; Lofton H; Vang Skjøth T; Stevenin B; Pi-Sunyer X
Diabetes Obes Metab; 2016 Apr; 18(4):430-5. PubMed ID: 26744025
[TBL] [Abstract][Full Text] [Related]
9. EFFECTS OF LIRAGLUTIDE 3.0 MG ON WEIGHT AND RISK FACTORS IN HISPANIC VERSUS NON-HIPANIC POPULATIONS: SUBGROUP ANALYSIS FROM SCALE RANDOMIZED TRIALS.
O'Neil PM; Garvey WT; Gonzalez-Campoy JM; Mora P; Ortiz RV; Guerrero G; Claudius B; Pi-Sunyer X;
Endocr Pract; 2016 Nov; 22(11):1277-1287. PubMed ID: 27482610
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of liraglutide for weight management in children and adolescents: a systematic review and meta-analysis of randomized controlled trials.
Gou H; Zhai Y; Guo J
Eur J Pediatr; 2023 Nov; 182(11):5095-5108. PubMed ID: 37672063
[TBL] [Abstract][Full Text] [Related]
11. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.
Vilsbøll T; Christensen M; Junker AE; Knop FK; Gluud LL
BMJ; 2012 Jan; 344():d7771. PubMed ID: 22236411
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial.
Whicher CA; Price HC; Phiri P; Rathod S; Barnard-Kelly K; Reidy C; Thorne K; Asher C; Peveler R; McCarthy J; Holt RIG
Trials; 2019 Nov; 20(1):633. PubMed ID: 31747930
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of subcutaneous semaglutide in adults with overweight or obese: a subgroup meta-analysis of randomized controlled trials.
Zhang R; Hou QC; Li BH; Deng L; Yang YM; Li TX; Yao XQ; Yang LL; Lin XL; Liao YQ; Wang L; Liu YP; Tan J; Wan ZW; Shuai P
Front Endocrinol (Lausanne); 2023; 14():1132004. PubMed ID: 37455913
[TBL] [Abstract][Full Text] [Related]
14. Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis.
Sun F; Chai S; Li L; Yu K; Yang Z; Wu S; Zhang Y; Ji L; Zhan S
J Diabetes Res; 2015; 2015():157201. PubMed ID: 25688373
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials.
O'Neil PM; Aroda VR; Astrup A; Kushner R; Lau DCW; Wadden TA; Brett J; Cancino AP; Wilding JPH;
Diabetes Obes Metab; 2017 Nov; 19(11):1529-1536. PubMed ID: 28386912
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review.
Xie Z; Yang S; Deng W; Li J; Chen J
Clin Epidemiol; 2022; 14():1463-1476. PubMed ID: 36510488
[TBL] [Abstract][Full Text] [Related]
17. Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial.
Neeland IJ; Marso SP; Ayers CR; Lewis B; Oslica R; Francis W; Rodder S; Pandey A; Joshi PH
Lancet Diabetes Endocrinol; 2021 Sep; 9(9):595-605. PubMed ID: 34358471
[TBL] [Abstract][Full Text] [Related]
18. Green tea for weight loss and weight maintenance in overweight or obese adults.
Jurgens TM; Whelan AM; Killian L; Doucette S; Kirk S; Foy E
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD008650. PubMed ID: 23235664
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of liraglutide in the obese, non-diabetic individuals: a systematic review and meta-analysis.
Zhang P; Liu Y; Ren Y; Bai J; Zhang G; Cui Y
Afr Health Sci; 2019 Sep; 19(3):2591-2599. PubMed ID: 32127832
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
